Abstract
The majority of human NK cells express low affinity IgG Fc receptors (CD16+), whereas a minor subset of NK cells lack Fc receptor expression (CD16-). In contrast to CD16+ NK cells that express only p75 IL-2 receptors, CD16- NK cells constitutively co-express both p75 and p55 IL-2 receptors in vivo and preferentially respond to low concentrations of IL-2 with increased cytolytic activation and proliferation. Scatchard analysis demonstrated the presence of approximately 1,200 high affinity (approximately 25 pM kD) and approximately 9,600 intermediate affinity (approximately 2 nM kD) IL-2 receptors on CD16- NK cells. CD16+ NK cells expressed only a single intermediate affinity IL-2 receptor of approximately 1.9 nM kD (approximately 9,000 sites per cell). The IL-2 binding data thus substantiated the phenotypic and functional studies and definitively show that the differential responsiveness of CD16- and CD16+ NK cells to IL-2 is manifested through different affinity IL-2 receptors.
MeSH Terms
Antigens, CD/analysis
Antigens, Differentiation/analysis
Cells, Cultured
Cytotoxicity, Immunologic
Flow Cytometry
Fluorescent Antibody Technique
Humans
Immunoglobulin G
Interleukin-2/metabolism
Killer Cells, Natural/immunology
Kinetics
Receptors, Fc/analysis
Receptors, IgG
Receptors, Interleukin-2/biosynthesis,metabolism
Chemicals
Antigens, CD
Antigens, Differentiation
Immunoglobulin G
Interleukin-2
Receptors, Fc
Receptors, IgG
Receptors, Interleukin-2
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Nagler A
Becton Dickinson Monoclonal Center, Inc., San Jose, California 95131.
Lanier L L
Phillips J H
References (16)
16 references, click to expand
-
In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy.
J Clin Oncol. 1987 Dec;5(12):1933-41
PMID: 3500280
-
The interleukin 2 receptor. Functional consequences of its bimolecular structure.
J Exp Med. 1987 Oct 1;166(4):1055-69
PMID: 3116143
-
Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies.
Proc Natl Acad Sci U S A. 1989 Mar;86(6):1982-6
PMID: 2467293
-
Functional heterogeneity of Leu 19"bright"+ and Leu 19"dim"+ lymphokine-activated killer cells.
J Immunol. 1989 Apr 15;142(8):2949-54
PMID: 2467946
-
Activation of natural killer cells via the p75 interleukin 2 receptor.
J Exp Med. 1989 Jul 1;170(1):291-6
PMID: 2787381
-
Comparative studies of human FcRIII-positive and negative natural killer cells.
J Immunol. 1989 Nov 15;143(10):3183-91
PMID: 2530273
-
Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells.
Clin Immunol Immunopathol. 1990 Jan;54(1):126-33
PMID: 2403487
-
Response of resting human peripheral blood natural killer cells to interleukin 2.
J Exp Med. 1984 Oct 1;160(4):1147-69
PMID: 6434688
-
Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
J Immunol. 1985 Feb;134(2):794-801
PMID: 3871216
-
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
J Immunol. 1986 Jun 15;136(12):4480-6
PMID: 3086432
-
Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.
J Exp Med. 1986 Sep 1;164(3):814-25
PMID: 3489062
-
Natural killer cells: definition of a cell type rather than a function.
J Immunol. 1986 Nov 1;137(9):2735-9
PMID: 3489775
-
Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.
J Exp Med. 1987 Jan 1;165(1):223-38
PMID: 3098894
-
Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.
Proc Natl Acad Sci U S A. 1986 Dec;83(24):9694-8
PMID: 3099289
-
A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors.
Nature. 1987 Jun 11-17;327(6122):518-22
PMID: 3108674
-
Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.
J Exp Med. 1989 Apr 1;169(4):1323-32
PMID: 2784485